Pharmacological Treatment of Obesity
Year: 2019
Type: book-chapter
Abstract: The prevalence of obesity and overweight has risen substantially in the past few decades. It is a public health problem that is associated with significant increase in morbidity and mortality, and a reduction in health-related quality of life [ 1 , 2 ]. Obesity is defined by the World Health Organization (WHO) based on body mass index (BMI). BMI is defined as an individual’s weight in kilograms divided by height in meters squared. A BMI between 18.5 and 25 is considered to be a normal weight, a BMI between 25 and 30 is classified as overweight, and a BMI of more than 30 is considered obese [ 3 , 4 ]. Among Asians, a BMI of 23 or higher is overweight, and a BMI of 27 or higher is obese, due to increased incidence of obesity-related complications at lower BMI.
Source: Nutrition and Diabetes
DOI: 10.1201/b22121-7
Authors: Amie A. Ogunsakin, Ayotunde O. Dokun
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,790
OpenAlex ID: W2952109606